Laminopathies and lamin‐associated signaling pathways
- 11 March 2011
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 112 (4) , 979-992
Abstract
Laminopathies are genetic diseases due to mutations or altered post‐translational processing of nuclear envelope/lamina proteins. The majority of laminopathies are caused by mutations in the LMNA gene, encoding lamin A/C, but manifest as diverse pathologies including muscular dystrophy, lipodystrophy, neuropathy, and progeroid syndromes. Lamin‐binding proteins implicated in laminopathies include lamin B2, nuclear envelope proteins such as emerin, MAN1, LBR, and nesprins, the nuclear matrix protein matrin 3, the lamina‐associated polypeptide, LAP2alpha and the transcriptional regulator FHL1. Thus, the altered functionality of a nuclear proteins network appears to be involved in the onset of laminopathic diseases. The functional interplay among different proteins involved in this network implies signaling partners. The signaling effectors may either modify nuclear envelope proteins and their binding properties, or use nuclear envelope/lamina proteins as platforms to regulate signal transduction. In this review, both aspects of lamin‐linked signaling are presented and the major pathways so far implicated in laminopathies are summarized. J. Cell. Biochem. 112: 979–992, 2011.Keywords
This publication has 123 references indexed in Scilit:
- Significance of host cell kinases in herpes simplex virus type 1 egress and lamin-associated protein disassembly from the nuclear laminaVirology, 2010
- Puma is required for p53-induced depletion of adult stem cellsNature Cell Biology, 2010
- Functional Coupling between the Extracellular Matrix and Nuclear Lamina by Wnt Signaling in ProgeriaDevelopmental Cell, 2010
- Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis functionProceedings of the National Academy of Sciences, 2010
- Phosphorylation statuses at different residues of lamin B2, B1, and A/C dynamically and independently change throughout the cell cycleExperimental Cell Research, 2010
- Autosomal-Dominant Distal Myopathy Associated with a Recurrent Missense Mutation in the Gene Encoding the Nuclear Matrix Protein, Matrin 3The American Journal of Human Genetics, 2009
- A quantitative atlas of mitotic phosphorylationProceedings of the National Academy of Sciences, 2008
- Lamin A-dependent misregulation of adult stem cells associated with accelerated ageingNature Cell Biology, 2008
- HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cellsProceedings of the National Academy of Sciences, 2007
- The inner nuclear membrane protein Emerin regulates β‐catenin activity by restricting its accumulation in the nucleusThe EMBO Journal, 2006